Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Ovranette Supply Problem

The manufacturer of Ovranette® has written to healthcare professionals to advise of a short-term difficulty affecting production that is limiting supplies. Weekly updates of supply difficulties are posted on the manufacturers website.

The product contains ethinylestradiol 30mcg and levonorgestrel 150mcg per tablet and is supplied in packs containing 63 tablets.

Microgynon 30 contains the same active ingredients and is available in the same pack size. It may therefore be a suitable alternative.

Action: Clinicians may need to prescribe alternative contraceptive medication to patients who are unable to source ovranette from pharmacies. Microgynon appears to be a suitable substitute.

Share 'Ovranette Supply Problem' on Email Share 'Ovranette Supply Problem' on Delicious Share 'Ovranette Supply Problem' on Digg Share 'Ovranette Supply Problem' on Facebook Share 'Ovranette Supply Problem' on Google+ Share 'Ovranette Supply Problem' on reddit Share 'Ovranette Supply Problem' on StumbleUpon Share 'Ovranette Supply Problem' on Twitter

atomic-wealth

No Comments to “Ovranette Supply Problem”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,616 spam comments.

atomic-wealth
fond-illness
summer